
|Articles|September 15, 2004
Allergan enters patent battle over generic version of brimonidine tartrate solution
Irvine, CA-Allergan Inc. said it has filed a lawsuit against Alcon Laboratories Inc. claiming that the Fort Worth, TX company infringed upon Allergan's patents for brimonidine tartrate ophthalmic solution 0.15% to manufacture a generic alternative to its Alphagan P drops.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
2
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
3
Opuviz aflibercept biosimilar launches in Europe for retinal diseases
4
Study links alcohol consumption to earlier advanced presbyopia in men
5





















